These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10461060)

  • 1. Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer.
    Xiangming C; Hokita S; Natsugoe S; Tanabe G; Baba M; Takao S; Kuroshima K; Aikou T
    Oncology; 1999; 57(2):131-7. PubMed ID: 10461060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot research for the correlation between the expression pattern of E-cadherin-β-catenin complex and lymph node metastasis in early gastric cancer.
    Yoshii T; Miyagi Y; Nakamura Y; Kobayashi O; Kameda Y; Ohkawa S
    Tumori; 2013; 99(2):234-8. PubMed ID: 23748820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
    Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
    Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival.
    Jawhari A; Jordan S; Poole S; Browne P; Pignatelli M; Farthing MJ
    Gastroenterology; 1997 Jan; 112(1):46-54. PubMed ID: 8978342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers.
    Joo YE; Rew JS; Kim HS; Choi SH; Park CS; Kim SJ
    Digestion; 2001; 64(2):111-9. PubMed ID: 11684825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastasis.
    Czyzewska J; Guzińska-Ustymowicz K; Ustymowicz M; Pryczynicz A; Kemona A
    Folia Histochem Cytobiol; 2010 Jan; 48(1):37-45. PubMed ID: 20529814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer.
    Cai J; Ikeguchi M; Tsujitani S; Maeta M; Liu J; Kaibara N
    Gastric Cancer; 2001; 4(2):66-74. PubMed ID: 11706763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers.
    Wang YW; Zhu ML; Wang RF; Xue WJ; Zhu XR; Wang LF; Zheng LZ
    Tumour Biol; 2016 Jul; 37(7):8567-78. PubMed ID: 26733174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
    Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
    J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
    Liu J; Ikeguchi M; Nakamura S; Kaibara N
    J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer.
    Jin EH; Lee DH; Jung SA; Shim KN; Seo JY; Kim N; Shin CM; Yoon H; Jung HC
    World J Gastroenterol; 2015 Jan; 21(2):571-7. PubMed ID: 25593477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of cadherin-catenin complex in association with the clinicopathologic features of early gastric cancer.
    Xiangming C; Hokita S; Nuruki K; Toyoyama H; Tanabe G; Baba M; Takao S; Aikou T
    Surg Today; 1998; 28(6):587-94. PubMed ID: 9681606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of liver-intestine cadherin and its correlation with lymph node metastasis in gastric cancer: can it predict N stage preoperatively?
    Park SS; Kang SH; Park JM; Kim JH; Oh SC; Lee JH; Chae YS; Kim SJ; Kim CS; Mok YJ
    Ann Surg Oncol; 2007 Jan; 14(1):94-9. PubMed ID: 17063305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
    Yoshida R; Kimura N; Harada Y; Ohuchi N
    Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the expression of E-cadherin and beta-catenin in bladder cancer.
    Garcia del Muro X; Torregrosa A; Muñoz J; Castellsagué X; Condom E; Vigués F; Arance A; Fabra A; Germà JR
    Eur J Cancer; 2000 Feb; 36(3):357-62. PubMed ID: 10708937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases.
    He Q; Chen J; Lin HL; Hu PJ; Chen MH
    Chin Med J (Engl); 2007 Sep; 120(17):1498-504. PubMed ID: 17908458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histopathological and immunohistochemical evaluation of lymph node metastasis in superficial esophageal cancer--with reference to the expression of E-cadherin and alpha-catenin].
    Tamura S; Shiozaki H; Kadowaki T; Inoue M; Oka H; Matsui S; Mori T
    Nihon Geka Gakkai Zasshi; 1995 Aug; 96(8):550-6. PubMed ID: 7565577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical expression of the E-cadherin-catenin complex in gastric cancer].
    Guzmán P; Araya J; Villaseca M; Roa I; Melo A; Muñoz S; Roa J
    Rev Med Chil; 2006 Aug; 134(8):1002-9. PubMed ID: 17130988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.